New Study On Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules CII Shows Administration Of Vyvanse Through Two Different Routes | Psydir News
Links shared publicly online about this topic.
- 1,656total visits
New Study On Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules CII Shows Administration Of Vyvanse Through Two Different Routes | Psydir News
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when admini...
View full resource at news.psydir.com
Tags: ADHD, ADHD Medication, Disease and Condition, Drug, Vyvanse, Pharmacokinetics, Shire
Most Recently Shared on October 23, 2009 at 2:55 pm By:
New Study On Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules CII Shows Administration Of Vyvanse Through Two Diff... http://ow.ly/15WR2Z
Advertisement
